$NUGN Investment DD Package Created by @Kavy09
Publicly traded company NuGene International Inc. (OTC Pink: NUGN) announces the completion of a change in control with Livento Group LLC, a Delaware Corporation. (3/17/2022)
Livento entered the OTC via Reverse Merger, merging into the shell NUGN (Nugene International) with a very attractive share structure for investors. It is currently one of the very few OTC companies without any debt as it was all settled prior to the Reverse Merger.
“Livento Group is a US-based company focused on disruptive business models. Livento is a dynamic organization looking for businesses that can deliver value and strong growth. Founded five years ago, we are in continuous development of our own AI & machine learning portfolio system, and the start of the BOXO movie production brand. “ (Quoted from Liventogroup.com)
“Acquisition and merger with NuGene International Inc. delivered the opportunity to boost the value of our business and expand it on a global scale. Our ultimate target is to be listed on major world exchanges so large investors across the globe can participate in our projects.” (Quoted from Liventogroup.com)
Three Business Models:
1. Real estate (Prague Czech Republic) own hotels and many other properties.
2. Artificial Intelligence and Consulting for Hedge fund portfolios.
3. Film and TV production. **Currently owns 15% of Eurodot. Eurodot revenue 2021; $12 million. Eurodot 2022 projected revenue; $50 million. Livento has opportunities to obtain 100% ownership of Eurodot.
**2022 Real Estate sales = 8 million
**Artificial Intelligence on trial with a Billion-dollar Hedge Fund that’s produced +/- 1 over the last year. Hedge Funds averaged -15% for the same time period.
Ticker Security Details:
Authorized Shares = 800m
Outstanding Shares = 209m
Public Float = 168m
Market Cap = 7.8m (7/15/22)
**Livento Group coordinated share structure with Custodian to ensure share structure met Livento Group standards prior to merger agreement. Coordination resulted in cancellation of over 500 million Outstanding Shares.
$NUGN projections for 2022-2023
Six films to be produced in 2022 with projected sales of $50 million/each film from box office over three years. (Total = $300 million)
First film: Stan Lee’s, Carnival of Killers w/projected 280M Box Office Sales
12 films to be produced in 2023.
10-12 streaming shows in cooperation with Netflix and Amazon.
Top Netflix shows production budget = 13M per episode
Netflix pays 30% on top of production budget to Producers
Short Term Catalysts:
Currently waiting for name change from OTC Markets. Will transition from Nugene International, Inc. to Livento Group, Inc.
OTCQB application submitted. Form 211 filed (will help immensely with limiting MM manipulation)
Quarterly filings currently being finalized and to be filed in July,2022 per Justin Mathews.
Currently waiting for updates to CEO David Stybr’s Miami/LA trip where he secured the rights to three more films.
Future releases of casting for upcoming films/series.
The Movie “Medieval” produced by BOXO will be released in theatres on Sept 8 2022. The movie has famous actors like Michael Caine and Ben Foster. Box office sales and production revenue will be very attractive for investors.
The Movie “Wash me in the River” with Robert Deniro & John Malkovich produced by BOXO will be released in the near future.
AI
